Literature DB >> 22218717

The diagnostic value of Ki-67, P53 and P63 in distinguishing partial Hydatidiform mole from hydropic abortion.

Yunxin Chen1, Danhua Shen, Yiqun Gu, Pingping Zhong, Junlin Xie, Qiujin Song.   

Abstract

BACKGROUND AND AIMS: The aim of the present study was to investigate the expression of Ki-67, P53 and P63 in hydropic abortion and partial mole and to explore possible role of these three parameters in distinguishing partial mole from hydropic.
METHODS: The hydropic abortion (n = 13) and partial mole (n = 23) were retrieved from the files of 2002 to 2010 at the Department of Pathology, Peking University People's Hospital and Department of Pathology, Haidian Maternal and Child Health Hospita1. All cases had typical histological features and complete clinical information. All pathologic diagnoses were reviewed by two gynaecologic pathologists and had no conflict. All cases showed P57 negative, which can exclude the diagnosis of CHM. An immunochemical study of the expressions of Ki-67, P53 and P63 was performed.
RESULTS: Microscopically, the pathologic characteristics of a HA include villous oedema with minimal to no cistern formation and mild trophoblastic hyperplasia. In contrast, the pathologic features of PHM were characterized by focal trophoblastic hyperplasia and a variable degree of hydropic swelling with central cistern formation. The Ki-67 expression was observed in the nuclear of cytotrophoblastic cell and intermediate trophoblasts population within placental tissue. The Ki-67 expression in HA is less than that in PHM. The p53 expression was observed in the nuclear of cytotrophoblastic cell and intermediate trophoblasts population within placental tissue. There was a significant difference between HA and PHM. Positive staining for P63 was localized in the nuclei of cytotrophoblastic cell population. No significant difference was observed in positive rate of p63 expression between HA and PHM.
CONCLUSION: The high Ki-67 labeling index and over-expression of p53, detected by immunohistochemistry, could serve as useful adjuncts to conventional methods of diagnosis in distinguishing PHM from HA. Due to, however, the limited samples, it needs to expand the number of the cases to verify this conclusion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22218717     DOI: 10.1007/s00508-011-0119-4

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  9 in total

1.  Expression of the p53 gene and apoptosis in gestational trophoblastic disease.

Authors:  R Halperin; S Peller; J Sandbank; I Bukovsky; D Schneider
Journal:  Placenta       Date:  2000-01       Impact factor: 3.481

2.  Interobserver and intraobserver variability in the diagnosis of hydatidiform mole.

Authors:  Masaharu Fukunaga; Hidetaka Katabuchi; Tetsuro Nagasaka; Yoshiki Mikami; Sachiko Minamiguchi; Janice M Lage
Journal:  Am J Surg Pathol       Date:  2005-07       Impact factor: 6.394

3.  p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study.

Authors:  D P Schammel; T Bocklage
Journal:  Int J Gynecol Pathol       Date:  1996-04       Impact factor: 2.762

4.  Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.

Authors:  A Kale; F Söylemez; A Ensari
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

5.  P63 expression in hydropic abortion and gestational trophoblastic diseases.

Authors:  L N Z Ramalho; M S Maggiori; A Ribeiro-Silva; L C Peres
Journal:  Placenta       Date:  2005-07-18       Impact factor: 3.481

6.  Expressions of p53, proliferating cell nuclear antigen, and Ki-67 in gestational trophoblastic diseases.

Authors:  A K Uzunlar; F Yilmaz; G Bayhan; Z Akkuş
Journal:  Eur J Gynaecol Oncol       Date:  2002       Impact factor: 0.196

7.  Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.

Authors:  Thomas G McConnell; Kathleen M Murphy; Michael Hafez; Russell Vang; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2009-06       Impact factor: 6.394

Review 8.  Current management of gestational trophoblastic diseases.

Authors:  Ross S Berkowitz; Donald P Goldstein
Journal:  Gynecol Oncol       Date:  2008-10-12       Impact factor: 5.482

9.  The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques.

Authors:  E Sabattini; K Bisgaard; S Ascani; S Poggi; M Piccioli; C Ceccarelli; F Pieri; G Fraternali-Orcioni; S A Pileri
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

  9 in total
  5 in total

1.  Immunohistochemical Analysis of E-Cadherin, p53 and Inhibin-α Expression in Hydatidiform Mole and Hydropic Abortion.

Authors:  Onur Erol; Dinç Süren; Birsel Tutuş; Tayfun Toptaş; Ahmet Arda Gökay; Aysel Uysal Derbent; Mustafa Kemal Özel; Cem Sezer
Journal:  Pathol Oncol Res       Date:  2015-12-18       Impact factor: 3.201

2.  Diagnostic value of P63 in differentiating normal gestation from molar pregnancy.

Authors:  Mitra Heidarpour; Marzieh Khanahmadi
Journal:  J Res Med Sci       Date:  2013-06       Impact factor: 1.852

3.  Immunohistochemistry Study of P53 and C-erbB-2 Expression in Trophoblastic Tissue and Their Predictive Values in Diagnosing Malignant Progression of Simple Molar Pregnancy.

Authors:  Malihe Hasanzadeh; Norrie Sharifi; Marjaneh Farazestanian; Seyed Saman Nazemian; Faezeh Madani Sani
Journal:  Iran J Cancer Prev       Date:  2016-06-13

4.  Apoptosis and p53 expression in the placental villi of females with unexplained recurrent spontaneous abortion.

Authors:  Dehua Wei; Qinghua Wu; Huirong Shi
Journal:  Exp Ther Med       Date:  2013-11-11       Impact factor: 2.447

5.  Abnormal expression of microRNA-575 leads to missed abortion through regulating apoptosis and angiogenesis.

Authors:  Shuqin Xia; Yihui Zhen; Hongsheng Ma; Aiming Wang
Journal:  Exp Ther Med       Date:  2017-08-31       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.